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ABSTRACT
Introduction: Obesity and type 2 diabetes (T2D) are
highly prevalent among African migrants compared
with European descent populations. The underlying
reasons still remain a puzzle. Gene–environmental
interaction is now seen as a potential plausible factor
contributing to the high prevalence of obesity and T2D,
but has not yet been investigated. The overall aim of
the Research on Obesity and Diabetes among African
Migrants (RODAM) project is to understand the
reasons for the high prevalence of obesity and T2D
among sub-Saharan Africans in diaspora by (1)
studying the complex interplay between environment
(eg, lifestyle), healthcare, biochemical and (epi)genetic
factors, and their relative contributions to the high
prevalence of obesity and T2D; (2) to identify specific
risk factors within these broad categories to guide
intervention programmes and (3) to provide a basic
knowledge for improving diagnosis and treatment.
Methods and analysis: RODAM is a multicentre
cross-sectional study among homogenous sub-
Saharan African participants (ie, Ghanaians) aged
>25 years living in rural and urban Ghana, the
Netherlands, Germany and the UK (http://rod-am.eu/).
Standardised data on the main outcomes, genetic and
non-genetic factors are collected in all locations. The
aim is to recruit 6250 individuals comprising five
subgroups of 1250 individuals from each site. In
Ghana, Kumasi and Obuasi (urban stratum) and
villages in the Ashanti region (rural stratum) are served
as recruitment sites. In Europe, Ghanaian migrants are
selected through the municipality or Ghanaian
organisations registers.
Ethics and dissemination: Ethical approval has
been obtained in all sites. This paper gives an overview
of the rationale, conceptual framework and methods of
the study. The differences across locations will allow
us to gain insight into genetic and non-genetic factors
contributing to the occurrence of obesity and T2D and
will inform targeted intervention and prevention
programmes, and provide the basis for improving
diagnosis and treatment in these populations and
beyond.
INTRODUCTION
Ethnic minority and migrant populations in
Europe have been disproportionately affected
by obesity and diabetes compared with the
host European origin populations (hence-
forth, Europeans).1–4 The prevalence of type
2 diabetes (T2D) in these populations, for
example, is about three to ﬁve times higher
than in Europeans.4 They also develop T2D at
a younger age; and they have higher morbid-
ity and mortality from T2D and related com-
plications such as cardiovascular disease
(CVD) than European populations.4 5 The
little available information suggests that
sub-Saharan Africa (SSA) migrants are par-
ticularly affected by obesity and T2D.3 In the
Health Survey for England (HSE) 2004, the
prevalence rates of T2D were 16.2% and 6%
in SSA men and women aged ≥35 years com-
pared with 5.1% and 2.4% in English general
population men and women, respectively.6
Obesity and T2D prevalence rates are not
only escalating among SSA migrants, but also
in their home countries. The increasing levels
of obesity and T2D in SSA countries have been
unprecedented and pose huge challenges for
many countries. While T2D seemed to be vir-
tually absent, for example, in West Africa in
the 1960s and 1980s (0.2–1.7%), today it has
become a major health problem affecting
almost 7% of the adult population.7–10
Projections indicate that the number of T2D
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patients in SSA will double from 14.7 million in 2011 to 28
million in 2020,11 undoubtedly among one of the highest
growth rates of T2D worldwide.11 12 This correlates with
the simultaneous increase of obesity in the same region.7
A systematic review found that the prevalence of obesity in
urban West Africa has more than doubled over the past
15 years.9 The serious cardiovascular complications of
obesity and T2D could overwhelm SSA countries that are
already straining under the burden of communicable
diseases.
The reasons for the increased susceptibility of ethnic
minority groups and migrants to obesity and T2D are
poorly understood. Increased T2D prevalence and com-
plications in African populations in SSA and industria-
lised countries have been attributed to delayed diagnosis
and poor management due to low socioeconomic status.
However, ethnic differences persist even when demo-
graphic, socioeconomic status, behavioural and clinical
parameters have been taken into account,13 suggesting
that other factors such as genetic predispositions might
be important. The validity of this ﬁnding, nonetheless, is
limited because of the heterogeneity of migrants studied
so far. Heritability estimates for T2D range up to
40%,14 15 but genetic variations thus far identiﬁed con-
tribute only a small fraction of the inherited risk.16
While genetic factors alone cannot explain the increas-
ing prevalence of obesity and T2D, it is clear that the
high prevalence of obesity and T2D is a result of a
complex interplay of environmental and genetic factors
that are likely to vary in different settings and among dif-
ferent population groups. Genetic predispositions and
interactions between environmental and genetic factors
may be involved in the onset and development of dis-
eases such as obesity and T2D among migrant popula-
tions. The ‘thrifty genotype’ and ‘thrifty phenotype’
hypotheses are considered to be the underlying mechan-
ism of the gene–environment interaction contribution
to disease susceptibility.17–21 While gene–environment
interactions may play an important role in disease sus-
ceptibility, research in this area, particularly within the
context of human migration, is in its infancy.
The high levels of obesity and T2D among migrant
populations may also be inﬂuenced by lifestyle changes
following migration3 as well as psychological stress.22
Evidence from cohort studies demonstrate the import-
ance of lifestyle factors such as physical inactivity and
smoking on obesity and T2D.23–27 However, among
migrant populations, interventions to reduce obesity and
T2D have often been ineffective,28 and efforts often fail
to meet the speciﬁc needs of ethnic minority and
migrant populations.29 The local circumstances of
ethnic minority and migrant populations, such as socio-
economic development of the groups, race relations and
access to healthcare and preventive services, may differ
greatly among industrialised countries.30 31 These differ-
ential contexts can inﬂuence health behaviour, psycho-
social stress and healthcare use among ethnic minority
and migrant groups, and subsequently lead to
differences in CVD health outcomes between similar
populations living in different countries.
The Research on Obesity and Diabetes among African
Migrants (RODAM) project—an European Commission
funded project—aims to understand the reasons for the
high prevalence of obesity and T2D among African
migrants by (1) studying the complex interplay between
environmental exposures and genetics and their relative
contributions to the high prevalence of obesity and
T2D; (2) to identify speciﬁc risk factors within these
broad categories to guide intervention programmes and
(3) to provide a basic knowledge for improving diagno-
sis and treatment. A conceptual model of the RODAM
project is presented in ﬁgure 1.32 It shows that following
migration, migrants may be exposed to varied contexts,
such as different opportunities for socioeconomic devel-
opment, different availability of food supply, different
health systems and policies and different cultural tradi-
tions; and these differences may inﬂuence their health
behaviour, physical and psychosocial stress and subse-
quently lead to differences in obesity and T2D risks.
METHODS
To achieve RODAM study goals, a multidisciplinary con-
sortium of researchers from Europe (University of
Amsterdam, Utrecht University, London School of
Hygiene and Tropical Medicine, Charité—
Universitätsmedizin Berlin, German Institute of Human
Nutrition) and Africa (University of Ghana, Kwame
Nkrumah University of Science and Technology and the
International Diabetes Federation (IDF), African
region) with broad experience on chronic diseases in
Africans and African migrants have joined forces. As a
central feature of the RODAM project, at all study sites,
highly standardised protocols of quantitative and qualita-
tive assessments are applied for participant recruitment
and topic-related investigations.
Study population
Assessing the role of gene–environmental interactions in
risk factors, such as obesity and T2D, among migrant
populations requires a highly standardised approach
and relatively homogeneous migrating and non-
migrating populations. For this reason, we concentrate
on a relatively homogenous SSA migrant population to
enable comparisons of the prevalence of obesity and
T2D between SSA migrants living in different European
countries and their compatriots living in rural and
urban SSA as outlined in the WHO Global Consultation on
Migrant Health report.33 Consequently, adult Ghanaians
(aged ≥25 years) are recruited in rural and urban
Ghana, and in the cities of Amsterdam, Berlin and
London. Ghanaians are one of the largest SSA migrant
groups in Europe.34–36 The 2009 estimates by the Ofﬁce
for National Statistics recorded 93 000 Ghanaian-born
people living in the UK. The majority of Ghanaians in
the UK are concentrated in London boroughs of
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Southwark, Lambeth, Newham, Hackney, Haringey,
Lewisham, Croydon, Merton and Brent.34 In Germany,
22 000 people are ofﬁcially registered as Ghanaians, the
majority of whom are concentrated in Berlin, Hamburg
and North-Rhine Westphalia.35 In the Netherlands, in
2009, there were approximately 20 000 ofﬁcially
recorded Ghanaians. The majority of these are concen-
trated in southeast Amsterdam.36
Recruitment of the study participants
Engagement of Ghanaian community
Previous work in the Netherlands and a feasibility study
among African communities in the UK show that
involvement of the community leaders enhances study
participation and may help prevent a low response rate
relating to language barriers and lack of understanding
about the relevance of the study.37 38 The RODAM
project, therefore, involves the Ghanaian community
leaders in all sites. This includes working with religious
communities (eg, churches and mosques), endorsement
from local key ﬁgures and establishing relationships with
healthcare organisations that serve these groups. In add-
ition, the project team provides information about the
study via local media aim at the Ghanaian population
(eg, Ghanaian radio and TV stations).
Owing to differences in the population registration
systems across European countries as well as in Ghana,
different approaches are needed for the recruitment of
the study populations across different locations. For
example, there is a population register in the
Netherlands where the Ghanaian migrants could be
identiﬁed and randomly selected for the study. In
Ghana, the UK and Germany, the situation is quite dif-
ferent as there are no population registers that will allow
for the easy identiﬁcation of these populations. It is
important, however, to adopt the recruitment strategies
that are comparatively as similar as possible across differ-
ent locations. We describe below the various recruitment
strategies in each site.
Recruitment strategy in Ghana
In Ghana, two cities (Kumasi and Obuasi) and 15 vil-
lages in the Ashanti region are served as the urban and
rural recruitment sites. The initial sampling frame was
the list of enumeration areas (EAs) in the Ashanti
region from the 2010 census. A multistage random sam-
pling procedure was adopted to arrive at the sampling of
30 EAs. EAs were stratiﬁed, weighted and a random
sample of rural and urban EAs was selected. There are
over 2000 urban EAs and more than 1000 rural EAs.
The ﬁrst stage was to group the districts into two main
categories: districts with a high number of urban
(Kumasi and Obuasi) areas and districts with a high
number of rural EAs. The next stage of sampling was to
put the EAs together in each of the categories and take
a weighted random sample of 10 for Kumasi and 5 for
Obuasi, respectively. The procedure was repeated for the
rural EAs by adding all the EAs in the selected districts
and weighted from the ﬁrst stage together after which a
simple random sample procedure was adopted to select
the total number of rural EAs (15) required for the
study. Letters are sent to all selected health and commu-
nity authorities to notify them of the start of the study.
We send team members to the various communities to
stay among them. Once within the community, the team
then organise mini clinics in the ﬁeld for a period of
1–2 weeks depending on the sampled population and
responsiveness of respondents.
Recruitment strategy in the Netherlands
In the Netherlands, Ghanaian participants were ran-
domly drawn from Amsterdam Municipal Health regis-
ter. This register contains data on country of birth of
citizens and their parents, thus allowing for sampling
based on the Dutch standard indicator for ethnic origin.
All selected participants aged ≥25 years were sent a
written invitation combined with written information
regarding the study and a opting out response card.
Participants are reminded by phone or home visit after
Figure 1 A conceptual model for the RODAM project.
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2 weeks if there is no response. After a positive response,
an appointment for physical examination at a local
health centre is made over the phone followed by a con-
ﬁrmation letter of the appointment, and a digital or
paper version of the questionnaire (depending on the
preference of the participant) is sent to the participant’s
home address.
Recruitment strategy in the UK
The UK has no population register for migrant groups.
Consequently, Ghanaian organisations are served as the
sampling frame. Lists of these organisations have been
obtained from the Ghanaian Embassy and the
Association of Ghanaian Churches in the UK in the bor-
oughs known to have the greatest concentration of
Ghanaians. Lists of all members of their organisations, if
available, have also been requested, from which a
number of all participants aged ≥25 years are invited to
participate in the study. The selected participants
receive a written invitation combined with written infor-
mation regarding the study and a opting out response
card. Participants are sent a conﬁrmation letter of the
appointment for a physical examination at a local health
centre, church or community centre, including a digital
or paper version of the questionnaire (depending on
the preference of the participant) if they agreed to par-
ticipate in the study.
Recruitment strategy in Germany
In Berlin, a list of Ghanaian individuals (born in Ghana,
or Ghanaian passport holders) was provided by the
registration ofﬁce and that was supplemented with
contact details of members of Ghanaian organisations
and churches in Berlin. From this combined list, all par-
ticipants aged ≥25 years have been invited to participate
in the study. In addition, a written invitation combined
with written information regarding the study and a
response card has been sent to the selected participants.
Participants are reminded after 2 weeks if there is no
response. After a positive response, the participants are
contacted by phone to schedule date and location of the
interview with a trained research assistant or opt for the
digital online version. Subsequent to the completion of
the questionnaire, a date for physical examination is
then scheduled.
Informed written consent is also obtained from each
participant prior to the enrolment in the study. In add-
ition, an external independent Ethical advisor has been
appointed by the RODAM Steering Committee to
oversee the ethical issues in the RODAM study.
Power and data analysis
In the presented study, we aim to sample 6250 indivi-
duals comprising ﬁve subgroups of 1250 each from the
ﬁve locations. For phenotypic, genetic and epigenetic
studies, subsets are selected. In order to estimate the
statistical power with regard to different sample sizes in
the three types of data, we evaluated three distinct types
of statistical power calculations with regard to the type of
survey.
Phenotypic association: For the phenotypic association
analysis, we assumed a prevalence of T2D of <5% in
rural Ghana, 6–7% in urban Ghana and >12% in
Europe.32 39 For obesity, we assumed a prevalence of
<5% in rural Ghana, 17% in urban Ghana and 30% in
Europe.2 39 In general, we aim for a power of 0.90 with
α=0.05 (including Bonferroni correction). Using these
parameters a sample size of approximately 1230 is
needed in the rural Ghana, urban Ghana, Amsterdam,
London and Berlin subsets to detect a difference
between the group proportions of 5%. T2D was deﬁned
as fasting plasma glucose ≥7 mmol/L, or pre-existing
antidiabetic medication or glycated haemoglobin
(HbA1c) ≥6.5%.40 Generalised obesity was deﬁned as
body mass index (BMI) ≥30 kg/m2, and central obesity
as a waist circumstance >102 cm in men or >88 cm in
women.41 42
Genetic association: The present study aims to geno-
type a substantial part of the total sample among
patients with diabetes (cases) and non-diabetes (con-
trols). The genotyping will be based on a standard
single nucleotide polymorphism array platform suitable
for performing genome-wide association study as well as
candidate gene analysis or related approaches. Using the
statistical power calculator on binary traits for a case–
control study design (S Purcell; http://pngu.mgh.
harvard.edu/), assuming an allele frequency of 0.25, a
prevalence of 16%, a relative risk of 1.3 and 1.6 (Aa and
AA rep.), a D’ of 1, the number of cases of 1000 (1:2
case–control ratio) and a type I error rate of 0.05,
approximately 540 cases are considered sufﬁcient to
obtain a power of 0.90. Although the latter necessary
sample size is covered by our study, it should be noted
that correction for multiple tests, that is, if more than
one genetic variant is tested, is not considered here.
Nevertheless, candidate gene or related association
approaches within this single study setup have sufﬁcient
statistical power to detect moderate and low effect sizes.
Epigenetic association: To explore the inﬂuence of
epigenetic factors on the main outcomes, we will ﬁrst
assess the differences in methylation levels among
Ghanaians living in rural and urban Ghana and Europe
and their relative contributions to the differences to
obesity and T2D that may be observed. With a study
power of 0.80 and α=0.05 (and SD±0.10%), at least 64
people per group are needed to detect a mean percent-
age difference in methylation density of 5%. When mul-
tiple correction is taken into account, about 300
individuals per group of participants are needed.
Epigenome-wide analysis will be performed. Association
analysis of the DNA methylation proﬁles and obesity and
T2D and related phenotypes will subsequently be per-
formed. Promising loci will then be validated using next-
generation bisulﬁte sequencing.
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Simple tables, proportions, mean and median values
will be used to examine the data. Multivariable linear
and logistics regression analyses will be used to assess the
differences and to identify speciﬁc relevant factors and
their relative contribution to the differences in body
indices and fasting glucose (continuous and binary
traits) between Ghanaian migrants and non-migrants.
Data collection
Data collection is composed of questionnaire/interviews,
physical examination and biological samples. The
methods for data collection in RODAM are identical in
all locations following standard operating procedures
and applying standardised tools. Questionnaires have
been adapted to the local circumstances in Ghana, the
Netherlands, the UK and Germany, where needed. For
example, for all sites, modiﬁcation of questions with
respect to educational system or social security system
was made. Before data collection, a 2-day training course
in the Netherlands was organised for all those involved
in data collection, on the overall project’s procedures.
The training involved the administration of the different
questionnaires, physical examinations, processing of
blood and urine samples in the laboratory and transport
and storage of samples. The work package leaders, in
turn, train all recruitment team members in each site on
all aspects of the study. Interviewers are recruited among
Ghanaian-speaking residents in Europe, are introduced
to the aims and procedures of the study and are
instructed and trained on the use of the questionnaires.
Research assistants also receive the online tutorial for
the Oracle Clinical data entry system. The performance
of each interviewer or research assistant is monitored
during the initial interviews and physical examinations.
Feedback is provided and changes were initiated if
needed. The RODAM coordinator monitors data collec-
tion at all study sites to ensure standardisation of
methods.
Questionnaire/interviews
All the participants who agree to participate in the study
receive an appointment for a structured interview. The
interviews are conducted by trained interviewers of
Ghanaian background and last for about 60–120 min. To
increase participation rate, the participants are given a
range of options including interviews in participants’
homes and digital or paper version of the questionnaire,
depending on the preference of the participant. The
interviewers conduct the interviews in the preferred lan-
guage of the respondent either in English, German,
Dutch or Ghanaian languages. The interview is based
on a structured health questionnaire, and contains ques-
tions on demographics (age, sex, marital status, house-
hold composition, religion), socioeconomic position
(education level and parental education, employment
status and parental employment status, occupational
status and wealth), migration-related factors (premigra-
tion history, age at ﬁrst migration, age at arrival in the
current location, duration of residence, cultural distance
and ethnic identity), psychosocial vulnerability (per-
ceived discrimination, social support, mastery, recent
negative life events and current depression), health
status (self-reported general health and presence and
history of diseases, family history of diseases), and health
behaviour (eg, dietary behaviour, physical activity,
alcohol and smoking, perceived body weight and body
shape and adherence to medications) by using appropri-
ate validated instruments (table 1). For example, phys-
ical activity is measured using the WHO Global Physical
Activity Questionnaire (GPAQ) V.2.43 Dietary behaviour
is determined by a Food Propensity Questionnaire
(FPQ), speciﬁcally developed in RODAM to include
Ghana-speciﬁc foods. In addition, a 24 h dietary recall
questionnaire will be administered to a subset of the
study population in each site (n=5*100).
All participants who complete the questionnaire are
invited for physical examination in the local research
clinic or in a health centre. At the start of the visit, the
study and the procedures involved are explained to each
participant and informed consent is signed if not
already carried out so at home.
After informed consent is given, physical measure-
ments are made and biological samples, fasting blood
and urine samples are collected.
Physical measurements
Physical examinations are performed with validated
devices according to standardised operational proce-
dures. Physical examinations comprise assessment of
anthropometrics (weight, height, trunk, waist circumfer-
ence and hip circumference), Bioimpedance Analysis
(BIA), blood pressure and Ankle-Brachial Index (ABI)
measures (table 2). The portable stadiometer SECA 217
is used for height measurement, the SECA 877 for
weight measurement, measuring tape for abdominal
and hip circumference and BODYSTAT 1500 MDD ana-
lyser for BIA. Blood pressure is measured three times
using validated semiautomated device (The Microlife
WatchBP home) with appropriate cuffs in a sitting pos-
ition after at least 5 min rest. ABI is measured with The
Microlife WatchBP Ofﬁce ABI with appropriate cuffs in
a supine position after at least 10 min rest. Each partici-
pant receives a summary of his/her main results accom-
panied by an explanation and the recommendation to
contact his/her GP if the results are abnormal.
Biological material
Blood samples
Fasting venous blood samples are collected by trained
research assistants in all sites. All blood samples are
manually processed and aliquoted immediately after col-
lection by a trained technician or research assistant
according to standard operational procedures, and then
temporarily stored at the local research location.
Immediate processing and cryopreservation at the
research location has the advantage of preserving any
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highly labile molecules in the samples. Standardised pro-
cedures ensure that each sample is collected, handled,
processed, transported and stored in the same way across
the sites. The samples are then transported to the
respective local laboratories (Durrer Center for
Cardiogenetic Research at the AMC, Amsterdam; Kwame
Nkrumah University of Science and Technology, KCCR,
Kumasi, Faculty of Infectious and Tropical Diseases,
LSHTM, London & Institute of Tropical Medicine and
International Health, Berlin), where samples are
checked, registered and stored at −80°C. These samples
include EDTA whole blood, heparin plasma and serum.
In addition, on the spot, fasting plasma glucose level is
assessed by validated hand-held device (Accu-Chek
Performa metre+Accu-Chek Inform II test strip (Roche,
Germany) in all sites to provide accurate glucose deter-
mination as blood glucose concentration tends to decline
over time in blood samples.53
Morning urine sample
Participants are asked to bring the ﬁrst early morning
urine in a clean jar. The urine sample is tested with a
Table 1 Variables measured in the RODAM questionnaire
Themes Variable/measure Questionnaire instrument/measures
Demographics Age, sex, marital status, religion, tribe, locality –
Socioeconomic
status
1. Education
2. Employment status
3. Wealth
4. Parental socioeconomic status
1. Education attainment
2. Nature of work
3. Household index; wealth index (only in
Ghana)
4. Father’s and mother’s education
attainment and profession
Migration-related
factors
Generation, duration of residence in Europe, religion,
cultural distance, migration history
–
Health status 1. General health
2. Presence and history of diseases and family history
of diseases
1. SF-1244
2. Various health conditions
Psychosocial factors 1. Perceived discrimination
2. Perceived social support
3. Dealing with everyday problems
4. Recent experiences (stressful life events)
5. Psychological stress
6. Recent well-being
1. Everyday Discrimination Scale45
2. SSQT Satisfaction Emotional Support
subscale46
3. Mastery47
4. List of threatening experiences48
5. 2 items from INTERHEART49
6. Patient Health Questionnaire-950
Health behaviour 1. Smoking
2. Alcohol intake
3. Physical activity
4. Dietary behaviour
5. Perceived body weight and body shape
6. Adherence to medication
1. –
2. –
3. WHO GPAQ V.243
4. Ghana-specific FPQ, 24-h dietary recalls
for subsample (n=5*100)
5. Pulvers instrument to measure body
image51
6. Self-reported adherence52
FPQ, Food Propensity Questionnaire; GP, general practitioner; GPAQ, Global Physical Activity Questionnaire; RODAM, Research on Obesity
and Diabetes among African Migrants; SSQT, Social Support Questionnaire for Transactions.
Table 2 Physical examination variables measured in RODAM
Themes Measures Instrument
Anthropometrics 1. Weight
2. Height and trunk
3. Waist circumference
4. Hip circumference
5. Body fat (Bio Impedance Analysis)
1. SECA 877
2. SECA 217
3. Measuring tape
4. Measuring tape
5. BODYSTAT 1500 MDD analyser for BIA
Blood pressure Systolic and diastolic blood pressure, measured
3 times in a sitting position after at least 5 min rest
The Microlife WatchBP home
Ankle-Brachial Index Ankle-Brachial Index, measured in a supine
position after at least 10 min rest
The Microlife WatchBP Office ABI
RODAM, Research on Obesity and Diabetes among African Migrants.
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dipstick in the Urysis 1100 (Combur 7, Roche) on the
spot, to determine pH, glucose, ketones, leucocytes,
nitrite, protein and erythrocytes. One sample per partici-
pant is transported, together with the blood samples, to
the respective local laboratory and stored at −80°C.
Transfer of biological material to dedicated centres for
biochemical analyses and genotyping
From the local research centres, the two aliquoted
samples, one urine sample and a 2 mL EDTA are then
transported to Berlin for biochemical analyses including
glucose metabolism (fasting glucose, HbA1c, insulin),
lipid proﬁle (total cholesterol, high-density lipoprotein
cholesterol, low-density lipoprotein cholesterol and trigly-
cerides), electrolytes and renal function (creatinine,
albumin, sodium, potassium, calcium), uric acid metabol-
ism (uric acid), liver metabolism (alanine transaminase,
aspartate aminotransferase, γ-glutamyl transpeptidase),
oxidative status and iron metabolism (ferritin) and
inﬂammation (high-sensitivity C reactive protein); and a
4 mL EDTA whole blood sample is transported to
Nottingham for DNA extraction and genotyping.
Shipping of the samples from European sites is carried
out using styrofoam boxes ﬁlled with dry ice and from
Ghana in dry shippers ﬁlled with liquid nitrogen.
Numerous factors including temperature, packaging,
courier, sample type, import/export requirements,
seasons, costs and transit time/ship days can affect bio-
logical specimen integrity during transportation domes-
tically and internationally. Hence, staff involved with
shipping the specimens have been trained in order to
minimise factors that might affect the integrity of the spe-
cimens. In addition, training regarding legal or regula-
tory aspects of shipment of specimens such as Material
Transfer Agreement (MTA) has been given. Each centre
maintains a shipment log to record the receipt and dis-
semination of shipments sent from the centre. Each ship-
ment entry is given a unique shipment number.
Qualitative interviews of perception and knowledge of
obesity and T2D
Interventions to reduce obesity and T2D have often
been ineffective particularly in migrant populations.28
This may, in part, relate to poor perceptions and knowl-
edge about both conditions. Access to preventive and
curative services may depend on a wide range of factors
including knowledge of services and how to use them,
health beliefs and attitudes, language barriers, the sensi-
tivity of services to differing needs and the quality of
care provided. Gaining in-depth insight into these
factors requires qualitative methodology. Thirty-two indi-
vidual interviews with people with diabetes and eight
focus groups (including up to eight participants per
group) with lay healthy individuals will be held at each
location. Segmentation categories for purposive sam-
pling for people with diabetes are gender, duration of
diabetes, BMI status and age. Each individual interview
and focus group interview is conducted by trained
interviewers using the same themes across all sites and
had duration of 60–90 min. Interviews are recorded,
transcribed and analysed using qualitative data software.
A coding framework of themes is developed based on
the RODAM theoretical framework and social represen-
tations theory.54 55 Coding is carried out inductively and
deductively through a constant comparative approach.
All transcripts are coded separately by two independent
researchers and are systematically discussed and com-
pared for inter-rater reliability.
Current status of the study
The RODAM project study is currently enrolling partici-
pants from ﬁve localities in four countries. As of January
2014, we have examined and interviewed 3868 partici-
pants (rural n=1057, urban Ghana n=863, Amsterdam
n=1011, London n=597 and Berlin n=340) who fulﬁlled
the RODAM eligibility criteria. Blood and urine samples
from these participants have been stored at the local
sites in Ghana, Amsterdam, London and Berlin. Part of
these samples have been successfully shipped from the
study sites to Charité—Universitätsmedizin Berlin for
biochemical analyses, and to Source Bioscience in
Nottingham for DNA extraction. Genotyping will start
once all the data collection is completed. The data col-
lection for the qualitative part of the project is ongoing
in rural and urban Ghana, Amsterdam and London.
Database has been built and the outline of the data
storage structure has been deﬁned. The data analysis
will begin once the data cleaning is completed.
DISCUSSION
SSA migrants to Europe belong to one of the fastest
growing migrant groups in Europe today.56 The unprece-
dented high levels of CVDs and related risk factors, such as
obesity and T2D, have huge clinical care and public health
implications. Consequently, the need to get detailed insights
into the possible underlying determinants of obesity and
T2D and related complications to help support the prevent-
ive efforts as well as clinical management is increasingly
being recognised. This is particularly so in major European
cities where some of these populations form a major part of
the patient population.31 Simultaneously, African countries
are facing huge challenges regarding obesity and T2D and
related complications.7 9 This issue was recently highlighted
in the meeting of the general assembly of the United
Nations on Non-Communicable Diseases in 2011 as an
important epidemic of our times (http://www.un.org/en/
ga/president/65/issues/ncdiseases.shtml). Unfortunately,
the established health education and lifestyle interventions
mainly in the European host populations may not be
applied in migrant populations and other world regions
such as Africa because of differences in susceptibility, nutri-
tion, social circumstances and culture. Still, in Africa and
among African migrants, data are highly fragmentary and
based on heterogeneous populations. Consequently, the
magnitude of the problem is uncertain and the relative
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contribution of risk factors is undeﬁned. Thus, it is difﬁcult
to set rational priorities for targeted health interventions
and policies and to monitor progress towards set goals.
Knowledge on health-related outcomes that are directly
associated with the migration process will allow for the most
effective and appropriate use of interventions, efforts and
investments to improve and promote the health of these
populations.51
Comparative studies such as RODAM have an enormous
potential for migrant populations and for the countries
from which they have migrated from. For migrant popula-
tions, it provides indications of how exposure to different
environmental circumstances might inﬂuence health out-
comes. This is highly relevant in that the industrialised
countries themselves differ greatly in terms of opportun-
ities for socioeconomic development of the migrant
groups, race relations and access to healthcare and pre-
ventive services.57 These differential contexts can undoubt-
edly inﬂuence health behaviour and healthcare use
among migrant groups, and subsequently lead to differ-
ences in health outcomes between similar migrant popula-
tions living in different countries.30 32 For the countries of
origin, the rapid increases of obesity and T2D following
migration to high-income countries give a clear indication
of the vulnerability of the population left behind as many
of these countries continue to westernise.57
The high prevalence of obesity and T2D among migrant
groups obviously is a result of a multitude of different
factors. Thorough understanding of the factors is a pre-
requisite for efﬁcient intervention and prevention. The
rigorous characterisation of biochemical parameters and
speciﬁc environmental factors as well as epigenetic factors
will allow comparing the major pathophysiological aspects
of obesity and T2D between African migrants and their
compatriots who did not migrate. Epigenetic data have a
huge potential to point to, as yet, unrecognised patho-
physiological pathways in obesity and T2D, and thus reveal
options for improved diagnosis and treatment.
The RODAM project will deliver up-to-date data on
obesity and T2D among SSA migrants in Europe and
their home country. This will allow us to draw conclu-
sions on the magnitude of the problem and deduce the
attributable risk of migration from rural to urban envir-
onment as well as migration to Europe for obesity and
T2D. Our ﬁndings on the inﬂuence of migration (from
Africa to Europe) will help healthcare providers and
health policy stakeholders to better understand and
predict comparable developments in other African
populations and in other parts of the world; and to (re)
direct efforts to the most obvious changes induced by
migration that affect obesity and diabetes.
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